Research Articles
Research articles concerning NAFLD are extracted from PubMed. For each individual article, related therapeutic strategies, targets, drugs and associated diseases in NAFLDkb are presented with knowledge graphs.
stats1
stats2
stats3
stats4
Search for:
Obesity11722 records.
| Article ID | PMID | Source | Title | Publish Year | |
|---|---|---|---|---|---|
| A11034 | 31075323 | J Hepatol | The beneficial effects of Mediterranean diet over low-fat diet may be mediated by decreasing hepatic fat content. | 2019 | Details |
| A11037 | 31074909 | J Bone Miner Res | Nonalcoholic Fatty Liver Disease in The Rotterdam Study: About Muscle Mass, Sarcopenia, Fat Mass, and Fat Distribution. | 2019 | Details |
| A11040 | 31071683 | Endocr Connect | Steroid metabolomic signature of liver disease in nonsyndromic childhood obesity. | 2019 | Details |
| A11042 | 31071367 | J Hepatol | Outcomes of liver transplantation for non-alcoholic steatohepatitis: A European Liver Transplant Registry study. | 2019 | Details |
| A11048 | 31069057 | F1000Res | Recent advances in the understanding and management of polycystic ovary syndrome. | 2019 | Details |
| A11050 | 31067824 | J Clin Med | Lysosomal Acid Lipase as a Molecular Target of the Very Low Carbohydrate Ketogenic Diet in Morbidly Obese Patients: The Potential Effects on Liver Steatosis and Cardiovascular Risk Factors. | 2019 | Details |
| A11056 | 31064103 | Nutrients | Fermented Cordyceps militaris Extract Prevents Hepatosteatosis and Adipocyte Hypertrophy in High Fat Diet-Fed Mice. | 2019 | Details |
| A11057 | 31064058 | Int J Mol Sci | Cardio-Metabolic Disorders in Non-Alcoholic Fatty Liver Disease. | 2019 | Details |
| A11058 | 31063974 | Endocr Connect | Elevated serum neuregulin 4 levels in patients with hyperthyroidism. | 2019 | Details |
| A11060 | 31062641 | Adipocyte | PNPLA3-I148M: a problem of plenty in non-alcoholic fatty liver disease. | 2019 | Details |
| A11068 | 31060787 | J Clin Densitom | Moderation Effect of Handgrip Strength on the Associations of Obesity and Metabolic Syndrome With Fatty Liver in Adolescents. | 2019 | Details |
| A11072 | 31057993 | Cureus | Metabolic Syndrome in Patients with Non-alcoholic Fatty Liver Disease: A Community Based Cross-sectional study. | 2019 | Details |
| A11075 | 31055550 | Wiad Lek | Comorbidity severity index as a new tool for assessment of co-existing diseases in patients with non-alcoholic fatty liver disease at the carbohydrate metabolism disorder background and concomitant subclinical hypothyroidism. | 2019 | Details |
| A11076 | 31055525 | Wiad Lek | The role of endothelial dysfunction in the progression mechanisms of non-alcoholic steatohepatitis in patients with obesity and chronic kidney disease. | 2019 | Details |
| A11080 | 31054977 | Ann Hepatol | Interaction of TM6SF2 E167K and PNPLA3 I148M variants in NAFLD in northeast China. | 2019 | Details |
| A11082 | 31053512 | Clin Nutr | Low muscle mass and low muscle strength associate with nonalcoholic fatty liver disease. | 2019 | Details |
| A11083 | 31051410 | Atherosclerosis | The novel adipokine CTRP1 is significantly associated with the incidence of major adverse cardiovascular events. | 2019 | Details |
| A11085 | 31050979 | Wiad Lek | Association of nonalcoholic fatty liver disease with small intestine bacterial overgrowth in obese children. | 2019 | Details |
| A11087 | 31048208 | J Nutr Biochem | Metabolic dysfunction following weight regain compared to initial weight gain in a high-fat diet-induced obese mouse model. | 2019 | Details |
| A11090 | 31046673 | Mol Med | Increased proteinase 3 and neutrophil elastase plasma concentrations are associated with non-alcoholic fatty liver disease (NAFLD) and type 2 diabetes. | 2019 | Details |
| A11092 | 31045941 | AIDS | A gathering storm: HIV infection and nonalcoholic fatty liver disease in low and middle-income countries. | 2019 | Details |
| A11094 | 31045630 | Eur J Gastroenterol Hepatol | Comparison of anthropometric measurements for prediction of the atherosclerosis and liver histology in young adults with nonalcoholic fatty liver disease. | 2019 | Details |
| A11096 | 31044315 | Curr Diab Rep | Epigenetic Markers and Microbiota/Metabolite-Induced Epigenetic Modifications in the Pathogenesis of Obesity, Metabolic Syndrome, Type 2 Diabetes, and Non-alcoholic Fatty Liver Disease. | 2019 | Details |
| A11106 | 31040024 | Atherosclerosis | No association between aortic stiffness and liver steatosis in morbidly obese patients. | 2019 | Details |
| A11107 | 31039348 | Exp Cell Res | Epoxyeicosatrienoic intervention improves NAFLD in leptin receptor deficient mice by an increase in PGC1α-HO-1-PGC1α-mitochondrial signaling. | 2019 | Details |
| A11109 | 31038030 | Int J Vitam Nutr Res | Tissue Changes in the Development of Fatty Liver by Chronic Ingestion of Sucrose Associated with Obesity and Dyslipidemia in Rats. | 2019 | Details |
| A11112 | 31036494 | Ann Hepatol | Microbiota and nonalcoholic fatty liver disease/nonalcoholic steatohepatitis (NAFLD/NASH). | 2019 | Details |
| A11113 | 31035998 | BMC Med | Elevated plasma copeptin levels identify the presence and severity of non-alcoholic fatty liver disease in obesity. | 2019 | Details |
| A11115 | 31035507 | Nutrients | Pterostilbene Reduces Liver Steatosis and Modifies Hepatic Fatty Acid Profile in Obese Rats. | 2019 | Details |
| A11116 | 31035006 | Free Radic Biol Med | Repositioning of niclosamide ethanolamine (NEN), an anthelmintic drug, for the treatment of lipotoxicity. | 2019 | Details |
| A11117 | 31034714 | Mol Nutr Food Res | Pear Extract and Malaxinic Acid Reverse Obesity, Adipose Tissue Inflammation, and Hepatosteatosis in Mice. | 2019 | Details |
| A11125 | 31031702 | Front Endocrinol (Lausanne) | The Discovery and Development of Liraglutide and Semaglutide. | 2019 | Details |
| A11130 | 31029756 | J Ethnopharmacol | Antisteatotic and antioxidant activities of Thymbra spicata L. extracts in hepatic and endothelial cells as in vitro models of non-alcoholic fatty liver disease. | 2019 | Details |
| A11133 | 31028350 | Nat Rev Gastroenterol Hepatol | From NASH to HCC: current concepts and future challenges. | 2019 | Details |
| A11134 | 31027316 | Nutrients | Soluble CD163-Associated Dietary Patterns and the Risk of Metabolic Syndrome. | 2019 | Details |
| A11139 | 31025557 | Adv Clin Exp Med | Clinical outcomes of non-alcoholic fatty liver disease: Polish-case control study. | 2019 | Details |
| A11148 | 31023717 | Biol Open | Longitudinal characterization of diet-induced genetic murine models of non-alcoholic steatohepatitis with metabolic, histological, and transcriptomic hallmarks of human patients. | 2019 | Details |
| A11149 | 31022865 | Nutrients | Dietary Docosahexaenoic Acid (DHA) and Eicosapentaenoic Acid (EPA) Operate by Different Mechanisms to Modulate Hepatic Steatosis and Hyperinsulemia in fa/fa Zucker Rats. | 2019 | Details |
| A11155 | 31019719 | Glob Health Epidemiol Genom | Non-alcoholic fatty liver disease in Africa: a hidden danger. | 2019 | Details |
| A11157 | 31018719 | Expert Rev Gastroenterol Hepatol | Noninvasive monitoring of hepatic steatosis: controlled attenuation parameter and magnetic resonance imaging-proton density fat fraction in patients with nonalcoholic fatty liver disease. | 2019 | Details |
| A11160 | 31017556 | Int J Vitam Nutr Res | Turmeric and chicory seed have beneficial effects on obesity markers and lipid profile in non-alcoholic fatty liver disease (NAFLD). | 2019 | Details |
| A11161 | 31016455 | Obes Surg | The HAALT Non-invasive Scoring System for NAFLD in Obesity. | 2019 | Details |
| A11163 | 31014948 | Surg Obes Relat Dis | Risk factors and prevalence of liver disease in review of 2557 routine liver biopsies performed during bariatric surgery. | 2019 | Details |
| A11168 | 31013163 | Endocr Pract | FATTY KIDNEY DISEASE: A NEW RENAL AND ENDOCRINE CLINICAL ENTITY? DESCRIBING THE ROLE OF THE KIDNEY IN OBESITY, METABOLIC SYNDROME, AND TYPE 2 DIABETES. | 2019 | Details |
| A11172 | 31011312 | Case Rep Gastroenterol | Gut Microbiota Profiles in Nonalcoholic Fatty Liver Disease and Its Possible Impact on Disease Progression Evaluated with Transient Elastography: Lesson Learnt from 60 Cases. | 2019 | Details |
| A11173 | 31011302 | Gastroenterol Hepatol (N Y) | Diagnostic and Treatment Implications of Nonalcoholic Fatty Liver Disease and Nonalcoholic Steatohepatitis. | 2019 | Details |
| A11174 | 31011258 | World J Gastroenterol | Clinical characteristics of non-alcoholic fatty liver disease in Chinese adult hypopituitary patients. | 2019 | Details |
| A11179 | 31009793 | Clin Gastroenterol Hepatol | Risk Factors for Severe Liver Disease in Patients With Type 2 Diabetes. | 2019 | Details |
| A11182 | 31009107 | J Cell Biochem | Hypoxia inducible factor-1 promotes liver fibrosis in nonalcoholic fatty liver disease by activating PTEN/p65 signaling pathway. | 2019 | Details |
| A11183 | 31008924 | Medicine (Baltimore) | Metabolic characteristics of obese children with fatty liver: A STROBE-compliant article. | 2019 | Details |
| A11192 | 31004828 | Cell Mol Gastroenterol Hepatol | Metabolic Targets in Nonalcoholic Fatty Liver Disease. | 2019 | Details |
| A11194 | 31004758 | Clin Gastroenterol Hepatol | Increased Risk of Death in First Year After Liver Transplantation Among Patients With Nonalcoholic Steatohepatitis vs Liver Disease of Other Etiologies. | 2019 | Details |
| A11204 | 31000862 | J Pak Med Assoc | Expert Opinion: Use of sodium glucose co-transporter type-2 inhibitors in South Asian population -The Pakistan perspective. | 2019 | Details |
| A11207 | 30999670 | Cells | Therapeutic Application of Micellar Solubilized Xanthohumol in a Western-Type Diet-Induced Mouse Model of Obesity, Diabetes and Non-Alcoholic Fatty Liver Disease. | 2019 | Details |
| A11212 | 30993937 | Diabetes Metab J | Nonalcoholic Fatty Liver Disease and Diabetes: Part II: Treatment. | 2019 | Details |
| A11217 | 30991877 | Gut Microbes | High intake of dietary fructose in overweight/obese teenagers associated with depletion of Eubacterium and Streptococcus in gut microbiome. | 2019 | Details |
| A11218 | 30991446 | Hepatology | Incorporating Weight Loss Medications Into Hepatology Practice for Nonalcoholic Steatohepatitis. | 2019 | Details |
| A11222 | 30987634 | BMC Pediatr | Quick assessment with controlled attenuation parameter for hepatic steatosis in children based on MRI-PDFF as the gold standard. | 2019 | Details |
| A11224 | 30987010 | J Clin Med | Utility of ALT Concentration in Men and Women with Nonalcoholic Fatty Liver Disease: Cohort Study. | 2019 | Details |
| A11230 | 30983815 | World J Gastroenterol | Hepatocellular carcinoma surveillance: An evidence-based approach. | 2019 | Details |
| A11238 | 30978698 | J Mol Endocrinol | Humulus japonicus stimulates thermogenesis and ameliorates oxidative stress in mouse adipocytes. | 2019 | Details |
| A11245 | 30975991 | Nat Commun | Hepatocyte-specific loss of GPS2 in mice reduces non-alcoholic steatohepatitis via activation of PPARα. | 2019 | Details |
| A11247 | 30974975 | Hum Exp Toxicol | Aromatic aldehyde compound cuminaldehyde protects nonalcoholic fatty liver disease in rats feeding high fat diet. | 2019 | Details |
| A11259 | 30971408 | Dis Model Mech | Beneficial effects of exercise on gut microbiota functionality and barrier integrity, and gut-liver crosstalk in an in vivo model of early obesity and non-alcoholic fatty liver disease. | 2019 | Details |
| A11262 | 30970431 | Gut Liver | Improvement of Nonalcoholic Fatty Liver Disease Reduces the Risk of Type 2 Diabetes Mellitus. | 2019 | Details |
| A11269 | 30965381 | Z Gastroenterol | Nonalcoholic steatohepatitis (NASH) - current treatment recommendations and future developments. | 2019 | Details |
| A11270 | 30965331 | Ann Nutr Metab | Fetuin-B Links Nonalcoholic Fatty Liver Disease to Chronic Kidney Disease in Obese Chinese Adults: A Cross-Sectional Study. | 2019 | Details |
| A11273 | 30964704 | Am J Physiol Endocrinol Metab | Role of exercise-induced hepatokines in metabolic disorders. | 2019 | Details |
| A11277 | 30962478 | Nat Commun | Hepatic arginase 2 (Arg2) is sufficient to convey the therapeutic metabolic effects of fasting. | 2019 | Details |
| A11280 | 30959577 | Hepatology | Fructose Promotes Leaky Gut, Endotoxemia, and Liver Fibrosis Through Ethanol-Inducible Cytochrome P450-2E1-Mediated Oxidative and Nitrative Stress. | 2019 | Details |
| A11284 | 30958562 | Histol Histopathol | Modulatory effect of inulin with soya isoflavones on plasma lipid profile and liver SCD-18 index in rats with induced type-2 diabetes mellitus. | 2019 | Details |
| A11291 | 30952918 | Sci Rep | Randomized, Double-blind, Placebo-controlled Study of a Multispecies Probiotic Mixture in Nonalcoholic Fatty Liver Disease. | 2019 | Details |
| A11292 | 30952479 | J Formos Med Assoc | Risk stratification of non-alcoholic fatty liver disease across body mass index in a community basis. | 2019 | Details |
| A11307 | 30945694 | J Genet | Genetics of nonalcoholic fatty liver disease in Asian populations. | 2019 | Details |
| A11308 | 30945501 | Zhen Ci Yan Jiu | [Acupuncture improves hepatic lipid metabolism by suppressing oxidative stress in obese nonalcoholic fatty liver disease rats]. | 2019 | Details |
| A11310 | 30945129 | Curr Obes Rep | Nonalcoholic Fatty Liver Disease and Obesity Treatment. | 2019 | Details |
| A11312 | 30943987 | J Transl Med | Experimental non-alcoholic steatohepatitis in Göttingen Minipigs: consequences of high fat-fructose-cholesterol diet and diabetes. | 2019 | Details |
| A11313 | 30943218 | PLoS One | Lipidomic and transcriptomic analysis of western diet-induced nonalcoholic steatohepatitis (NASH) in female Ldlr -/- mice. | 2019 | Details |
| A11314 | 30942685 | Proc Nutr Soc | The influence of dietary fatty acids on liver fat content and metabolism. | 2019 | Details |
| A11315 | 30942551 | Obesity (Silver Spring) | Comparison of Abdominal Obesity and Fatty Liver and Their Association with Insulin Resistance and Metabolic Syndrome in Chinese Adults. | 2019 | Details |
| A11318 | 30940491 | Nutr Metab Cardiovasc Dis | Non alcoholic fatty liver disease and risk of incident diabetes in subjects who are not obese. | 2019 | Details |
| A11326 | 30936733 | Diabetes Metab Syndr Obes | Ethnic differences and heterogeneity in genetic and metabolic makeup contributing to nonalcoholic fatty liver disease. | 2019 | Details |
| A11332 | 30935037 | Nutrients | Melatonin Improves Fatty Liver Syndrome by Inhibiting the Lipogenesis Pathway in Hamsters with High-Fat Diet-Induced Hyperlipidemia. | 2019 | Details |
| A11333 | 30932788 | Int J Vitam Nutr Res | Strong association between serum Vitamin D and Vaspin Levels, AIP, VAI and liver enzymes in NAFLD patients. | 2019 | Details |
| A11334 | 30932777 | Int J Vitam Nutr Res | Ramadan fasting improves liver function and total cholesterol in patients with nonalcoholic fatty liver disease. | 2019 | Details |
| A11337 | 30931596 | Orv Hetil | [Alcoholic liver disease: the roles of genetic-epigenetic factors and the effect of abstinence]. | 2019 | Details |
| A11340 | 30931080 | Oxid Med Cell Longev | Cherry Anthocyanins Regulate NAFLD by Promoting Autophagy Pathway. | 2019 | Details |
| A11341 | 30930223 | J Hepatol | The circadian clock and liver function in health and disease. | 2019 | Details |
| A11344 | 30929337 | Zhonghua Gan Zang Bing Za Zhi | [Analysis of influencing factors and causes of death in elderly residents with non-alcoholic fatty liver disease]. | 2019 | Details |
| A11346 | 30928918 | BMJ Open | Impact of bacterial probiotics on obesity, diabetes and non-alcoholic fatty liver disease related variables: a systematic review and meta-analysis of randomised controlled trials. | 2019 | Details |
| A11347 | 30928418 | Dig Liver Dis | Different predictors of steatosis and fibrosis severity among lean, overweight and obese patients with nonalcoholic fatty liver disease. | 2019 | Details |
| A11357 | 30924429 | Proc Nutr Soc | From sugar to liver fat and public health: systems biology driven studies in understanding non-alcoholic fatty liver disease pathogenesis. | 2019 | Details |
| A11366 | 30920583 | Endocr Rev | The Liver-α-Cell Axis and Type 2 Diabetes. | 2019 | Details |
| A11373 | 30919338 | Adv Exp Med Biol | Circular RNAs as Potential Biomarkers and Therapeutic Targets for Metabolic Diseases. | 2019 | Details |
| A11377 | 30918952 | Inflamm Bowel Dis | Systematic Review With Meta-analysis: Epidemiology of Nonalcoholic Fatty Liver Disease in Patients With Inflammatory Bowel Disease. | 2019 | Details |
| A11378 | 30918873 | J Diabetes Metab Disord | Life-style-induced metabolic derangement and epigenetic changes promote diabetes and oxidative stress leading to NASH and atherosclerosis severity. | 2018 | Details |
| A11379 | 30918425 | World J Gastroenterol | Noninvasive evaluation of nonalcoholic fatty liver disease: Current evidence and practice. | 2019 | Details |
| A11383 | 30917662 | Rev Esp Enferm Dig | Characterizing specific subgroups in patients with NAFLD: overweight vs obese phenotype. | 2019 | Details |
| A11387 | 30916873 | Liver Int | Fibroblast growth factor 21 is independently associated with severe hepatic steatosis in non-obese HIV-infected patients. | 2019 | Details |
| A11394 | 30915401 | Clin Exp Hepatol | Small intestinal bacterial overgrowth and nonalcoholic fatty liver disease. | 2019 | Details |